In line with these findings, decreased levels of sHSPs have been identified in colorectal, pancreatic and renal malignancies [26], while increased levels of HSPB2 expression were found in breast cancer where it was proposed that HSPB2 possesses an anti-apoptotic role via inhibiting the extrinsic apoptotic pathway [47]. Here, HSPB2 is linked to breast cancer.